More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
Italy Publishes National Regulation Requiring Pharma Disclosure Of Public Support For R&D On New Drugs 28/07/2020 Svĕt Lustig Vijay Italy has become the first nation to require pharmaceutical companies to disclose secret data about any public subsidies it may have received for the development of a new drug, during negotiations over drug pricing and reimbursement with national regulatory authorities, according to a decree published Friday in the nation’s official gazette. The decree, following on […] Continue reading -> Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
Hepatitis B Incidence In Children Falls Under 1%, Reaching 2020 Target 27/07/2020 Svĕt Lustig Vijay In a landmark achievement, incidence of chronic hepatitis B has successfully dropped below 1% in children under five, reaching the 2020 goal set at the 2016 World Health Assembly, said World Health Organization Director-General Dr. Tedros Adhanon Ghebreyesus on Monday. The target reduction in hepatitis B virus (HBV) incidence in children was met in 2019, […] Continue reading -> Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
Moderna Launches Final Phase COVID-19 Vaccine Trial Following Patent Spat 27/07/2020 Grace Ren Moderna, a frontrunner in the COVID-19 vaccine development race, today entered the final phase of testing required before pursuing regulatory approval, beginning the Phase III trial for their vaccine candidate mRNA-1273. The trial, titled COVE (Coronavirus Efficacy), will measure how well a 100 microgram dose of the vaccine can protect people against developing symptomatic COVID-19 […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
Can New Leadership Fix The World Trade Organization’s Existential Crisis? 20/07/2020 Svĕt Lustig Vijay The race for the leadership of the World Trade Organization (WTO) gained traction this week as eight competing nominees presented their pitches to fill Azevêdo’s role to the WTO General Council, and later to the press and public. The nominees include: Ngozi Okonjo-Iweala, the chair of Gavi, the Vaccine Alliance, and former finance minister of […] Continue reading -> Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts
Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> Posts navigation Older postsNewer posts